Atlas Trials

Biomarkers of Injectable Extended Release Naltrexone Treatment

Clinical trial NCT02324725 · COMPLETED

Trial details

NCT number
NCT02324725
Sponsor
University of Pennsylvania
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Heroin DependenceOpioid Dependence
Start date
2011-10-01
Primary completion
2021-12-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.